Kevin J. Kenny - Jan 8, 2024 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role: President of Global Spine
Signature: /s/ Kimberley Elting, attorney-in-fact
Stock symbol: OFIX
Transactions as of: Jan 8, 2024
Transactions value $: -$20,081
Form type: 4
Date filed: 1/10/2024, 04:55 PM
Previous filing: Jan 9, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OFIX	Common Stock	Options Exercise	$0	+5.96K	+4.22%	$0.00	147K	Jan 8, 2024	Direct	F1
transaction	OFIX	Common Stock	Tax liability	-$20.1K	-1.51K	-1.03%	$13.29	146K	Jan 8, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OFIX	Performance Share Units	Options Exercise	$0	-5.96K	-100%	$0.00^*	0	Jan 8, 2024	Common Stock	5.96K	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Kevin J. Kenny is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	On April 4, 2023, the reporting person was granted 5,959 performance-based restricted stock units (PSUs). Such PSUs vested and converted to common stock on a one-for-one basis on January 8, 2024.
F2	Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The synergy target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy target is achieved), or 0% (if less than 80% of the Synergy Target is achieved).

Content

On April 4, 2023, the reporting person was granted 5,959 performance-based restricted stock units (PSUs). Such PSUs vested and converted to common stock on a one-for-one basis on January 8, 2024.

Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The synergy target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy target is achieved), or 0% (if less than 80% of the Synergy Target is achieved).